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Interest in the use of arterial grafts in coronary artery bypass grafting(CABG) has increased significantly for the following reasons: (1) Thenumber of patients receiving arterial grafts has risen sharply in most majorcardiac surgery centers around the world; (2) the number of arterial graftsreceived per patient has increased; (3) more diverse arteries are used asgrafts than previously; (4) more is understood about the biologic charac-
teristics of arterial grafts; (5) clinical protocols for the use of arterial grafts are more
advanced; and (6) midterm results with alternative arterial grafts are encouraging in
a large number of patients.
It is widely accepted that the left internal thoracic artery (ITA) is the artery of
choice for an arterial graft. Opinions differ, however, as to the second choice for an
arterial graft, which frequently depends on the personal preference of the surgeon.
The right ITA, the radial artery (RA), and the right gastroepiploic artery (GEA) are
the candidates for second choice for arterial grafts for CABG. In general, which
artery is chosen depends on the surgeon’s views about the quality of the graft, that
is, its length and diameter, whether the artery can be used as a pedicle graft, the
technical difficulties, the incidence of vasospasm, and the possible superior long-
term patency. Usually, pedicle grafts are considered to be superior to free grafts
because the anatomic structure of the pedicle artery is thought to be more intact (the
nerve and the blood supply to the vaso vasorum are better preserved in the pedicle
graft). On the other hand, for arterial grafts such as the GEA, the pattern of direct
flow from the ascending aorta in the free graft is better than that from the abdominal
aorta (in the in situ pedicle graft). Therefore, although the ITA is better used as a
pedicle graft than as a free graft, the GEA, when used as a free graft, has some
advantages with regard to the flow pattern.
Because the most important advantage for arterial grafts compared with vein
grafts is their superior long-term patency, any alteration of the technique used for all
kinds of arterial grafts should also take long-term patency into account. The
long-term patency of arterial grafts is related to many factors:
1. Biologic characteristics of the arterial grafts, including (a) graft diameter, (b)
the thickness of the wall and of the intimal hyperplasia, (c) the anatomic
structure of the graft, (d) the usable length of the graft and whether it can be
used as a pedicle graft, (e) the incidence of vasospasm, and (f) the incidence
of atherosclerosis and occlusion rate both in situ and in the grafts.
2. General risk factors for coronary artery disease such as diabetes mellitus,
hypertension, and hypercholesterolemia.
3. Anatomy and pathologic status of the target coronary artery, and disease
status of the native coronary artery, such as the degree of stenosis, the quality
of the wall, the flow capacity of the runoff, and the size of the vessel.
4. Vessel match between the graft and the target coronary artery.
5. The flow pattern through the graft, which may also be related to the patency.
6. Technical considerations, which depend primarily on the operative technique
of the surgeon.
7. Function of endothelium and smooth muscle: in particular, preservation of
endothelial function during the preparation of the graft is crucial to long-term
patency.
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8. Pharmacologic therapy: (a) perioperative antispastic
protocol for arterial grafts and (b) antiplatelet therapy
(aspirin) for long-term patency.
The surgeon can control some of the preceding factors
during surgery by doing the following:
1. Choosing an adequate graft.
2. Using a pedicle graft whenever possible.
3. Improving operative skills to reduce the risk of graft
occlusion by technical factors.
4. Using an adequate antispastic protocol during graft
preparation to reduce damage to the endothelium and
the smooth muscle of the graft.
Arterial grafts are small to mid-sized conduit arteries. A
major concern of arterial grafting is vasospasm in the graft
perioperatively. Because of the lack of data comparing these
grafts, we have no direct evidence that the incidence of
vasospasm in the free graft is higher or lower than that in the
pedicle graft.
Despite numerous studies on the causes of vasospasm in
arterial grafts in particular and in all kinds of vessels in
general, little is known about how vasospasm develops. The
correlation between vasospasm and the reactivity of a vessel
to vasoconstrictors is also unclear. However, it is presumed
that vasospasm is an extreme form of vasoconstriction that
may be the response of a vessel to many stimuli (spasmo-
gens). These stimuli may be physical (such as mechanical
stimulation or temperature change) or pharmacologic (such
as nerve stimulators or vasoconstrictor substances).
Important vasoconstrictor substances, which may act as
spasmogens for blood vessels,1 are (1) endothelium-derived
contracting factors such as endothelin, (2) prostanoids such
as thromboxane A2 and prostaglandin F2, (3) circulating
sympathomimetic substances (-adrenoceptor agonists)
such as norepinephrine and synthetic 1-adrenoceptor ago-
nists (methoxamine or phenylephrine), (4) platelet-derived
contracting substances such as 5-hydroxytryptamine and
thromboxane A2, (5) substances released from mast cells
and basophils such as histamine, (6) muscarinic receptor
agonists such as acetylcholine, (7) renin-angiotensin sys-
tem–related substances such as angiotensin II, (8) contract-
ing vasopressin substances, and (9) the depolarizing agent
potassium ion.
The contractility of arterial grafts in response to the
preceding vasoconstrictors has been studied extensively.
Although all arterial grafts react to these vasoconstrictors,
some arteries react to vasoconstrictors more strongly than
others do. This is best reflected by the fact that the GEA
reacts more strongly to the vasoconstrictors K, thrombox-
ane A2, endothelin-1, and norepinephrine than do other
arteries.2 Another example is that the RA reacts more
strongly to receptor-mediated contractions than does the
ITA.3 Clinically, although vasospasm may develop in all
arterial grafts, it develops more frequently in the GEA and
RA than in the ITA and inferior epigastric artery. Postop-
erative vasospasm and occlusion account for the early aban-
donment of the RA and is considered a possible cause for
abandoning the GEA in some cardiac surgical centers.
These studies led us to classify arterial grafts as type I
(somatic arteries), type II (splanchnic arteries), and type III
(limb arteries).2,4 Types II and III are more spastic. Vaso-
spasm is seen frequently in the GEA, as a type II artery,
during harvesting.
Further, vasospasm in arterial grafts is clearly related to
endothelial function. Our most recent studies show differ-
ences in the release of nitric oxide and endothelium-derived
hyperpolarizing factor,5,6 both between the ITA and the
saphenous vein and between the RA and ITA. Development
of vasospasm in the arterial graft is clearly related to endo-
thelial function. When endothelial function is damaged,
such as occurs with inadequate preparation of the graft, the
graft has a tendency to go into vasospasm.
In the article by Matsuura and colleagues in this issue of
the Journal [J Thorac Cardiovasc Surg 2001;121:520-5],
the authors developed a new method (transplantation of an
en bloc vascular system) for overcoming vasospasm in the
GEA. This method is characterized by two major points—
use of a free GEA graft and establishment of venous drain-
age.
The authors hypothesized that the vasospasm seen in the
GEA is related to disconnected venous return of the GEA
and the attached omental tissue because they observed
swelling of the free GEA graft. They therefore developed a
new technique to anastomose the venous return to the right
atrium to establish the circulation of the vaso vasorum.
Preliminary results indicate that this method seems to re-
duce swelling of the tissue. In the 33 patients observed, no
vasospasm occurred postoperatively. The authors concluded
that free GEA grafting and the venous drainage technique
prevent graft spasm, leading to an improved patency rate.
Before the method can be widely accepted, however,
several points should be emphasized:
First, as mentioned previously, the exact cause of vaso-
spasm is unknown. There are no data to support the authors’
hypothesis that the main cause of free graft spasm is graft
damage caused by interruption of venous drainage from the
graft. Also, the exact cause of vasospasm is still unknown.
The difference between the incidence of vasospasm in the
free GEA and that in the in situ GEA is not established.
Similarly, the incidence of vasospasm in the free right ITA
graft is not higher than that in the pedicled right ITA.
Second, the relationship between vasospasm in arterial
grafts and venous return is unclear. The authors’ hypothesis
is therefore premature. Again, in right ITA grafting, there is
usually no need for direct venous drainage to the right
atrium from the graft and vasospasm is not seen more
frequently in the right ITA. The authors also noticed that the
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need to establish venous return is unique for GEA, if there
is such a need.
Other aspects should also be carefully considered. First,
those who developed GEA grafting and who have per-
formed the procedure in a large number of patients, such as
Suma,7 Pym,8 and their associates, have not emphasized the
need to establish venous return for GEA. Others9 also
reported an 84.5% patency rate at 10 months and a 97%
early patency rate for GEA without performing the venous
anastomosis for venous return. The excellent results from
these experiences may lead one to question the necessity of
establishing venous return in the GEA graft. Second, it may
be unnecessary to establish venous return surgically in
skeletonized or semiskeletonized GEA grafts, as is the case
in other arterial grafts. Third, histologic studies10 have
shown that arterial grafts can be nourished through the
lumen, thereby indicating the possible presence of a venous
return mechanism directly to the lumen that is presumably
enough if there is no redundant tissue around the graft.
To support their hypothesis, the authors should have a
control group in which the free GEA graft is used without
venous drainage to the right atrium. The incidence of vaso-
spasm and the long-term patency should be compared in
these two groups. Without such a control, it would be
difficult to conclude that the establishment of the venous
return would reduce the incidence of vasospasm in the free
GEA graft. Further, anatomic studies may be necessary to
investigate the possible venous return mechanism through
the wall of the GEA directly to the lumen.
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